作者：
Coiffier,B. [1]
;
Radford,J. [2]
;
Bosly,A. [3]
;
Martinelli,G. [4]
;
Barca,G. [5]
;
Davies,A. [6]
;
Decaudin,D. [7]
;
Gallop-Evans,E. [8]
;
Padmanabhan-Iyer,S. [9]
;
VanEygen,K. [10]
;
Wu,K.L. [11]
;
Gupta,I.V. [12]
;
Lin,T.S. [13]
;
Goldstein,N. [14]
;
Jewell,R.C. [15]
;
Winter,P. ;
Lisby,S.
作者单位：
Department of Hematology, Ziekenhuis Stuivenberg, Antwerpen, Belgium
[1]
Genmab, Copenhagen, Denmark
[2]
Service d'Hématologie, Clinique Universitaires UCL de Mont-Godinne, Yvoir, Belgium
[3]
Departments of Medical Oncology and Translational Research, Institut Curie, Paris, France
[4]
GlaxoSmithKline, Collegeville, PA, United States
[5]
The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom
[6]
GlaxoSmithKline, Research Triangle Park, NC, United States
[7]
Oncologisch Centrum, AZ Groeninge, Kortrijk, Belgium
[8]
GlaxoSmithKline, London, United Kingdom
[9]
Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, United Kingdom
[10]
Institute for Drug Development, University of Texas Health Science Center at San Antonio, San
[11]
Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom
[12]
Service d'Hematologie, Hospices Civils de Lyon, Lyon, France
[13]
Divisione di Ematoncologia, Istituto Europeo di Oncologia, Milan, Italy
[14]
Department of Hematology, Coltea Clinical Hospital, Bucharest, Romania
[15]
发布时间
2014-01-21
换一批
